Clinical trials: Retention, Urinary
- Condition Retention, Urinary
- Funder type Industry (pharma, biotech, devices)
- Age group Children (under 18)
Bladder Disease, Bladder Retention Volume
ECHO-012 Kosmos Bladder Clinical Validation Study
The goal of this clinical trial is to compare the Kosmos Automatic Bladder Volume to the manual annotated bladder volume in participants across gender (male and female), age (children ages 7-17 and adults 18-89), and BMI strata…
- Conditions
- Bladder Disease, Bladder Retention Volume, Bladder Dysfunction, Bladder Function
- Trial name
- NCT06792851
- Testing
- Kosmos Bladder Volume Algorithm
- Where
- United States
- Volunteers
- 146 people, healthy volunteers welcome
- Sponsor
- EchoNous Inc.
Epilepsy
Risk of Urinary Retention With Retigabine
A prospective cohort study of antiepileptic drug (AED) polytherapy-treated epilepsy patients within the HealthCore Integrated Research Database (HIRD) will be conducted.
- Trial name
- NCT01462656
- Testing
- Non-EZG containing AED polytherapy, EZG containing AED polytherapy, Non-EZG AED monotherapy
- Volunteers
- 1 people
- Sponsor
- GlaxoSmithKline
Urge Incontinence, Urinary Retention
Patient Registry to Study the Tined Lead Used With the InterStim System For Urinary Control
The purpose of this study is assess the long-term safety and effectiveness of the InterStim tined lead using a minimally invasive approach.
- Trial name
- NCT00225966
- Testing
- Device Medtronic InterStim Tined Leads Models 3889 and 3093
- Where
- 2 sites in United States
- Volunteers
- 153 people
- Sponsor
- MedtronicNeuro
Epilepsy
REMS Retigabine Study
As part of a post-marketing commitment, GSK will conduct a survey of prescribers' and pharmacists' understanding of the risk of urinary retention with retigabine products.
- Trial name
- NCT01938560
- Testing
- Survey Responses
- Volunteers
- 1 people, healthy volunteers welcome
- Sponsor
- GlaxoSmithKline